Chan SYT - Search Results

1

Association of Sperm-Associated Antigen 5 and Treatment Response in Patients With Estrogen Receptor-Positive Breast Cancer.

Abdel-Fatah TMA, Ball GR, Thangavelu PU, Reid LE, McCart Reed AE, Saunus JM, Duijf PHG, Simpson PT, Lakhani SR, Pongor L, Gyorffy B, Moseley PM, Green AR, Pockley AG, Caldas C, Ellis IO, Chan SYT. Abdel-Fatah TMA, et al. Among authors: chan syt. JAMA Netw Open. 2020 Jul 1;3(7):e209486. doi: 10.1001/jamanetworkopen.2020.9486. JAMA Netw Open. 2020. PMID: 32633764 Free PMC article.

2

C-erbB2 expression predicts response to preoperative chemotherapy for locally advanced breast cancer.

Willsher PC, Pinder SE, Gee JM, Ellis IO, Chan SY, Nicholson RI, Blamey RW, Robertson JF. Willsher PC, et al. Anticancer Res. 1998 Sep-Oct;18(5B):3695-8. Anticancer Res. 1998. PMID: 9854479

3

A review of selective estrogen receptor modulators in the treatment of breast and endometrial cancer.

Chan S. Chan S. Semin Oncol. 2002 Jun;29(3 Suppl 11):129-33. doi: 10.1053/sonc.2002.34065. Semin Oncol. 2002. PMID: 12138407 Review.

4

The role of PTEN and its signalling pathways, including AKT, in breast cancer; an assessment of relationships with other prognostic factors and with outcome.

Panigrahi AR, Pinder SE, Chan SY, Paish EC, Robertson JF, Ellis IO. Panigrahi AR, et al. J Pathol. 2004 Sep;204(1):93-100. doi: 10.1002/path.1611. J Pathol. 2004. PMID: 15307142

5

Neoadjuvant chemotherapy in locally advanced primary breast cancers: the Nottingham experience.

Mathew J, Asgeirsson KS, Agrawal A, Mukherjee A, Ellis IO, Cheung KL, Chan SY, Robertson JF. Mathew J, et al. Eur J Surg Oncol. 2007 Oct;33(8):972-6. doi: 10.1016/j.ejso.2007.02.005. Epub 2007 Mar 27. Eur J Surg Oncol. 2007. PMID: 17391905 Clinical Trial.

6

Growth fraction as a predictor of response to chemotherapy in node-negative breast cancer.

Aleskandarany MA, Green AR, Rakha EA, Mohammed RA, Elsheikh SE, Powe DG, Paish EC, Macmillan RD, Chan S, Ahmed SI, Ellis IO. Aleskandarany MA, et al. Int J Cancer. 2010 Apr 1;126(7):1761-9. doi: 10.1002/ijc.24860. Int J Cancer. 2010. PMID: 19711345 Free article.

7

T cell density and location can influence the prognosis of ovarian cancer.

Al-Attar A, Shehata M, Durrant L, Moseley P, Deen S, Chan S. Al-Attar A, et al. Pathol Oncol Res. 2010 Sep;16(3):361-70. doi: 10.1007/s12253-009-9230-5. Epub 2009 Dec 19. Pathol Oncol Res. 2010. PMID: 20024633 Free article.

8

Estrogen receptor expression and docetaxel efficacy in patients with metastatic breast cancer: a pooled analysis of four randomized trials.

Andre F, Broglio K, Pusztai L, Berrada N, Mackey JR, Nabholtz JM, Chan S, Hortobagyi GN. Andre F, et al. Oncologist. 2010;15(5):476-83. doi: 10.1634/theoncologist.2009-0150. Epub 2010 Apr 26. Oncologist. 2010. PMID: 20421265 Free PMC article.

9

Topo2α protein expression predicts response to anthracycline combination neo-adjuvant chemotherapy in locally advanced primary breast cancer.

Mukherjee A, Shehata M, Moseley P, Rakha E, Ellis I, Chan S. Mukherjee A, et al. Br J Cancer. 2010 Dec 7;103(12):1794-800. doi: 10.1038/sj.bjc.6605960. Epub 2010 Nov 9. Br J Cancer. 2010. PMID: 21063406 Free PMC article.

10

Calpain-1 expression is associated with relapse-free survival in breast cancer patients treated with trastuzumab following adjuvant chemotherapy.

Storr SJ, Woolston CM, Barros FF, Green AR, Shehata M, Chan SY, Ellis IO, Martin SG. Storr SJ, et al. Int J Cancer. 2011 Oct 1;129(7):1773-80. doi: 10.1002/ijc.25832. Epub 2011 Mar 8. Int J Cancer. 2011. PMID: 21140455 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

173 results

Search Page